Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Conditions
Non Hodgkin Lymphoma · Richter Transformation · Multiple Myeloma · T-cell-prolymphocytic Leukemia · Acute Myeloid Leukemia · Acute Lymphocytic Leukemia · Myeodysplastic Syndrome · Myelodysplastic/Myeloproliferative Neoplasm · Myelofibrosis · Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Chronic Myelomonocytic Leukemia-2 · Myelodysplastic Neoplasm in Blast Phase
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Chicago, Chicago, Illinois, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of North Carolina, Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
University of Cincinnati, Cincinnati, Ohio, United States
The Ohio State University, Columbus, Ohio, United States
MD Anderson Cancer Center, Houston, Texas, United States
University of Utah, Salt Lake City, Utah, United States